572 related articles for article (PubMed ID: 18302710)
21. Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.
De Filippi P; Zecca M; Lisini D; Rosti V; Cagioni C; Carlo-Stella C; Radi O; Veggiotti P; Mastronuzzi A; Acquaviva A; D'Ambrosio A; Locatelli F; Danesino C
Br J Haematol; 2009 Dec; 147(5):706-9. PubMed ID: 19775298
[TBL] [Abstract][Full Text] [Related]
22. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
23. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy.
Loh ML; Mullighan CG
Clin Cancer Res; 2012 May; 18(10):2754-67. PubMed ID: 22589484
[TBL] [Abstract][Full Text] [Related]
24. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
Bresolin S; Zecca M; Flotho C; Trentin L; Zangrando A; Sainati L; Stary J; de Moerloose B; Hasle H; Niemeyer CM; Te Kronnie G; Locatelli F; Basso G
J Clin Oncol; 2010 Apr; 28(11):1919-27. PubMed ID: 20231685
[TBL] [Abstract][Full Text] [Related]
25. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.
Loh ML
Hematology Am Soc Hematol Educ Program; 2010; 2010():357-62. PubMed ID: 21239819
[TBL] [Abstract][Full Text] [Related]
26. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.
Shiba N; Taki T; Park MJ; Shimada A; Sotomatsu M; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Arakawa H; Hayashi Y
Br J Haematol; 2012 Feb; 156(3):413-4. PubMed ID: 21981547
[No Abstract] [Full Text] [Related]
27. The myelodysplastic syndromes.
Masey JA
Br J Biomed Sci; 1997 Mar; 54(1):65-70. PubMed ID: 9167309
[TBL] [Abstract][Full Text] [Related]
28. Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations.
Matsuda K; Yoshida N; Miura S; Nakazawa Y; Sakashita K; Hyakuna N; Saito M; Kato F; Ogawa A; Watanabe A; Sotomatsu M; Kobayashi C; Ito T; Ishida F; Manabe A; Kojima S; Koike K
Br J Haematol; 2012 Jun; 157(5):647-50. PubMed ID: 22348520
[No Abstract] [Full Text] [Related]
29. [Prognosis of 75 patients with juvenile myelomonocytic leukemia: prospective study by MDS committee in the Japanese Society of Pediatric Hematology].
Yoshida N; Hirabayashi S; Watanabe S; Zaike Y; Tsuchida M; Yoshimi A; Masunaga A; Otsuka Y; Ito M; Kojima S; Nakahata T; Manabe A
Rinsho Ketsueki; 2011 Dec; 52(12):1853-8. PubMed ID: 22241152
[TBL] [Abstract][Full Text] [Related]
30. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B
Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370
[TBL] [Abstract][Full Text] [Related]
31. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
[No Abstract] [Full Text] [Related]
32. [Molecular abnormalities and clonality in myelodysplastic syndromes].
Fenaux P; Preudhomme C
Pathol Biol (Paris); 1997 Sep; 45(7):556-60. PubMed ID: 9404479
[TBL] [Abstract][Full Text] [Related]
33. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).
Hasle H; Baumann I; Bergsträsser E; Fenu S; Fischer A; Kardos G; Kerndrup G; Locatelli F; Rogge T; Schultz KR; Starý J; Trebo M; van den Heuvel-Eibrink MM; Harbott J; Nöllke P; Niemeyer CM;
Leukemia; 2004 Dec; 18(12):2008-14. PubMed ID: 15496981
[TBL] [Abstract][Full Text] [Related]
34. Myelodysplastic syndromes.
Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G
Ann N Y Acad Sci; 2004 Dec; 1028():400-8. PubMed ID: 15650265
[TBL] [Abstract][Full Text] [Related]
35. Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML.
Hirabayashi S; Flotho C; Moetter J; Heuser M; Hasle H; Gruhn B; Klingebiel T; Thol F; Schlegelberger B; Baumann I; Strahm B; Stary J; Locatelli F; Zecca M; Bergstraesser E; Dworzak M; van den Heuvel-Eibrink MM; De Moerloose B; Ogawa S; Niemeyer CM; Wlodarski MW;
Blood; 2012 Mar; 119(11):e96-9. PubMed ID: 22238327
[TBL] [Abstract][Full Text] [Related]
36. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
[TBL] [Abstract][Full Text] [Related]
37. Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome.
Yanir AD; Krauss A; Stein J; Steinberg-Shemer O; Gilad O; Lotan SN; Dgany O; Krasnov T; Kodman Y; Feuerstein T; Mardoukh J; Fishman H; Geron I; Yacobovich J; Tamary H; Birger Y; Avrahami G; Izraeli S; Birenboim SB
Pediatr Blood Cancer; 2021 Oct; 68(10):e29138. PubMed ID: 34019335
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
39. Myelodysplastic syndrome in children and adolescents.
Niemeyer CM; Baumann I
Semin Hematol; 2008 Jan; 45(1):60-70. PubMed ID: 18179970
[TBL] [Abstract][Full Text] [Related]
40. Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
Romano M; Della Porta MG; Gallì A; Panini N; Licandro SA; Bello E; Craparotta I; Rosti V; Bonetti E; Tancredi R; Rossi M; Mannarino L; Marchini S; Porcu L; Galmarini CM; Zambelli A; Zecca M; Locatelli F; Cazzola M; Biondi A; Rambaldi A; Allavena P; Erba E; D'Incalci M
Br J Cancer; 2017 Jan; 116(3):335-343. PubMed ID: 28072764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
